vs
Postal Realty Trust, Inc.(PSTL)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Postal Realty Trust, Inc.的1.4倍($35.5M vs $26.0M),Postal Realty Trust, Inc.净利率更高(17.9% vs -304.2%,领先322.1%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs 21.7%),Postal Realty Trust, Inc.自由现金流更多($37.6M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs 22.6%)
Postal Realty Trust, Inc.是一家专业房地产投资信托基金,主要收购、持有和管理租给美国邮政服务的物业,资产组合覆盖美国各地的最后一公里邮政设施、分拣中心及零售邮政网点,为美国邮政及包裹配送基础设施提供支持。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
PSTL vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $26.0M | $35.5M |
| 净利润 | $4.6M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 39.2% | -304.8% |
| 净利率 | 17.9% | -304.2% |
| 营收同比 | 21.7% | 681.7% |
| 净利润同比 | 3.1% | 39.6% |
| 每股收益(稀释后) | $0.16 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $26.0M | $35.5M | ||
| Q3 25 | $24.3M | $5.2M | ||
| Q2 25 | $23.4M | $19.2M | ||
| Q1 25 | $22.1M | $14.7M | ||
| Q4 24 | $21.4M | $4.5M | ||
| Q3 24 | $19.7M | $26.1M | ||
| Q2 24 | $18.1M | $14.4M | ||
| Q1 24 | $17.3M | $13.8M |
| Q4 25 | $4.6M | $-108.1M | ||
| Q3 25 | $3.8M | $-162.3M | ||
| Q2 25 | $3.6M | $-171.9M | ||
| Q1 25 | $2.1M | $-202.5M | ||
| Q4 24 | $4.5M | $-178.9M | ||
| Q3 24 | $1.1M | $-95.8M | ||
| Q2 24 | $817.0K | $-97.5M | ||
| Q1 24 | $206.0K | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 39.2% | -304.8% | ||
| Q3 25 | 37.6% | -3327.6% | ||
| Q2 25 | 37.3% | -916.8% | ||
| Q1 25 | 28.4% | -1297.9% | ||
| Q4 24 | 43.2% | -4042.4% | ||
| Q3 24 | 24.3% | -377.1% | ||
| Q2 24 | 22.8% | -697.4% | ||
| Q1 24 | 17.6% | -698.4% |
| Q4 25 | 17.9% | -304.2% | ||
| Q3 25 | 15.7% | -3135.3% | ||
| Q2 25 | 15.5% | -894.2% | ||
| Q1 25 | 9.4% | -1373.3% | ||
| Q4 24 | 21.1% | -3935.5% | ||
| Q3 24 | 5.4% | -367.5% | ||
| Q2 24 | 4.5% | -676.6% | ||
| Q1 24 | 1.2% | -662.4% |
| Q4 25 | $0.16 | $-0.17 | ||
| Q3 25 | $0.13 | $-0.36 | ||
| Q2 25 | $0.12 | $-0.41 | ||
| Q1 25 | $0.06 | $-0.50 | ||
| Q4 24 | $0.17 | $-0.56 | ||
| Q3 24 | $0.03 | $-0.34 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $-0.01 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.5M | $743.3M |
| 总债务越低越好 | $361.1M | $9.6M |
| 股东权益账面价值 | $285.2M | $1.1B |
| 总资产 | $759.1M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.27× | 0.01× |
8季度趋势,按日历期对齐
| Q4 25 | $1.5M | $743.3M | ||
| Q3 25 | $1.9M | $659.8M | ||
| Q2 25 | $1.1M | $525.1M | ||
| Q1 25 | $639.0K | $500.5M | ||
| Q4 24 | $1.8M | $594.4M | ||
| Q3 24 | $970.0K | $427.6M | ||
| Q2 24 | $1.7M | $474.3M | ||
| Q1 24 | $1.9M | $296.3M |
| Q4 25 | $361.1M | $9.6M | ||
| Q3 25 | $347.0M | $11.9M | ||
| Q2 25 | $328.8M | $14.2M | ||
| Q1 25 | $306.7M | $16.4M | ||
| Q4 24 | $296.7M | $19.0M | ||
| Q3 24 | $277.0M | $20.5M | ||
| Q2 24 | $273.7M | $22.9M | ||
| Q1 24 | $247.6M | — |
| Q4 25 | $285.2M | $1.1B | ||
| Q3 25 | $273.9M | $1.0B | ||
| Q2 25 | $250.8M | $919.1M | ||
| Q1 25 | $245.5M | $933.9M | ||
| Q4 24 | $251.3M | $1.0B | ||
| Q3 24 | $245.6M | $524.6M | ||
| Q2 24 | $245.5M | $584.4M | ||
| Q1 24 | $248.1M | $401.2M |
| Q4 25 | $759.1M | $1.5B | ||
| Q3 25 | $735.2M | $1.4B | ||
| Q2 25 | $689.8M | $1.3B | ||
| Q1 25 | $654.0M | $1.3B | ||
| Q4 24 | $646.8M | $1.4B | ||
| Q3 24 | $615.1M | $726.5M | ||
| Q2 24 | $608.2M | $775.9M | ||
| Q1 24 | $584.1M | $557.8M |
| Q4 25 | 1.27× | 0.01× | ||
| Q3 25 | 1.27× | 0.01× | ||
| Q2 25 | 1.31× | 0.02× | ||
| Q1 25 | 1.25× | 0.02× | ||
| Q4 24 | 1.18× | 0.02× | ||
| Q3 24 | 1.13× | 0.04× | ||
| Q2 24 | 1.11× | 0.04× | ||
| Q1 24 | 1.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $44.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $37.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 144.5% | -133.1% |
| 资本支出强度资本支出/营收 | 26.7% | 3.5% |
| 现金转化率经营现金流/净利润 | 9.59× | — |
| 过去12个月自由现金流最近4个季度 | $65.6M | $-378.3M |
8季度趋势,按日历期对齐
| Q4 25 | $44.5M | $-46.1M | ||
| Q3 25 | $10.9M | $-117.4M | ||
| Q2 25 | $11.4M | $-76.4M | ||
| Q1 25 | $10.8M | $-132.0M | ||
| Q4 24 | $33.5M | $-115.4M | ||
| Q3 24 | $8.0M | $-59.2M | ||
| Q2 24 | $9.9M | $-82.2M | ||
| Q1 24 | $6.4M | $-102.3M |
| Q4 25 | $37.6M | $-47.3M | ||
| Q3 25 | $8.8M | $-117.6M | ||
| Q2 25 | $9.1M | $-79.6M | ||
| Q1 25 | $10.2M | $-133.8M | ||
| Q4 24 | $30.7M | $-116.7M | ||
| Q3 24 | $7.4M | $-63.8M | ||
| Q2 24 | $8.9M | $-83.4M | ||
| Q1 24 | $5.8M | $-109.0M |
| Q4 25 | 144.5% | -133.1% | ||
| Q3 25 | 36.1% | -2272.5% | ||
| Q2 25 | 38.8% | -413.9% | ||
| Q1 25 | 45.9% | -907.4% | ||
| Q4 24 | 143.8% | -2567.7% | ||
| Q3 24 | 37.6% | -244.6% | ||
| Q2 24 | 49.4% | -578.5% | ||
| Q1 24 | 33.6% | -789.9% |
| Q4 25 | 26.7% | 3.5% | ||
| Q3 25 | 8.9% | 4.7% | ||
| Q2 25 | 10.1% | 16.4% | ||
| Q1 25 | 3.0% | 12.4% | ||
| Q4 24 | 13.0% | 28.6% | ||
| Q3 24 | 3.2% | 17.5% | ||
| Q2 24 | 5.4% | 8.2% | ||
| Q1 24 | 3.5% | 48.2% |
| Q4 25 | 9.59× | — | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 3.16× | — | ||
| Q1 25 | 5.20× | — | ||
| Q4 24 | 7.44× | — | ||
| Q3 24 | 7.48× | — | ||
| Q2 24 | 12.10× | — | ||
| Q1 24 | 31.07× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图